RA0290

antibody from Oursmab

Targeting: HGF DFNB39, F-TCF, HGFB, HPTA, SF

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0290

Provider

Oursmab

Product name

Rilotumumab (Biosimilar Reference Antibody) (HGF)

Antibody type

Monoclonal

Description

Rilotumumab is a fully human monoclonal antibody targeting hepatocyte growth factor (HGF). It binds to HGF to prevent its interaction with the c-Met receptor, thereby inhibiting the HGF/c-Met signaling pathway involved in tumor growth, angiogenesis, and metastasis. It was investigated for the treatment of advanced solid tumors such as gastric cancer and glioblastoma.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Rilotumumab (Biosimilar Reference Antibody) (HGF)-RA0290-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Rilotumumab (Biosimilar Reference Antibody) (HGF)-RA0290 in a linear range of 15.63¨C125 ng/mL.